======= EXOSC7 =======
== Gene Information ==
* **Official Symbol**: EXOSC7
* **Official Name**: exosome component 7
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=23016|23016]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q15024|Q15024]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=EXOSC7&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20EXOSC7|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/606488|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Non-catalytic component of the RNA exosome complex which has 3'->5' exoribonuclease activity and participates in a multitude of cellular RNA processing and degradation events. In the nucleus, the RNA exosome complex is involved in proper maturation of stable RNA species such as rRNA, snRNA and snoRNA, in the elimination of RNA processing by-products and non-coding 'pervasive' transcripts, such as antisense RNA species and promoter-upstream transcripts (PROMPTs), and of mRNAs with processing defects, thereby limiting or excluding their export to the cytoplasm. The RNA exosome may be involved in Ig class switch recombination (CSR) and/or Ig variable region somatic hypermutation (SHM) by targeting AICDA deamination activity to transcribed dsDNA substrates. In the cytoplasm, the RNA exosome complex is involved in general mRNA turnover and specifically degrades inherently unstable mRNAs containing AU-rich elements (AREs) within their 3' untranslated regions, and in RNA surveillance pathways, preventing translation of aberrant mRNAs. It seems to be involved in degradation of histone mRNA. The catalytic inactive RNA exosome core complex of 9 subunits (Exo-9) is proposed to play a pivotal role in the binding and presentation of RNA for ribonucleolysis, and to serve as a scaffold for the association with catalytic subunits and accessory proteins or complexes.
|RNase PH C|
|RNase PH|
|U1 snRNA 3-end processing|
|U5 snRNA 3-end processing|
|nuclear polyadenylation-dependent mRNA catabolic process|
|polyadenylation-dependent mRNA catabolic process|
|nuclear polyadenylation-dependent tRNA catabolic process|
|nuclear polyadenylation-dependent ncRNA catabolic process|
|nuclear ncRNA surveillance|
|nuclear polyadenylation-dependent rRNA catabolic process|
|polyadenylation-dependent ncRNA catabolic process|
|AU-rich element binding|
|polyadenylation-dependent RNA catabolic process|
|tRNA catabolic process|
|exonucleolytic trimming involved in rRNA processing|
|U4 snRNA 3-end processing|
|exonucleolytic trimming to generate mature 3-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)|
|rRNA 3-end processing|
|nuclear-transcribed mRNA catabolic process, exonucleolytic, 3-5|
|cytoplasmic exosome (RNase complex)|
|nuclear RNA surveillance|
|exoribonuclease activity|
|nuclear mRNA surveillance|
|RNA surveillance|
|nuclear exosome (RNase complex)|
|exosome (RNase complex)|
|rRNA catabolic process|
|maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)|
|cleavage involved in rRNA processing|
|maturation of 5.8S rRNA|
|ncRNA catabolic process|
|snRNA 3-end processing|
|3-5-exoribonuclease activity|
|exonucleolytic catabolism of deadenylated mRNA|
|nuclear-transcribed mRNA catabolic process, exonucleolytic|
|snRNA processing|
|RNA phosphodiester bond hydrolysis, exonucleolytic|
|snRNA metabolic process|
|ncRNA 3-end processing|
|nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay|
|RNA 3-end processing|
|RNA phosphodiester bond hydrolysis|
|regulation of mRNA stability|
|regulation of RNA stability|
|tRNA metabolic process|
|nuclear-transcribed mRNA catabolic process|
|regulation of mRNA catabolic process|
|rRNA processing|
|mRNA catabolic process|
|rRNA metabolic process|
|RNA catabolic process|
|nucleic acid phosphodiester bond hydrolysis|
|ribosome biogenesis|
|regulation of mRNA metabolic process|
|nucleobase-containing compound catabolic process|
|ncRNA processing|
|heterocycle catabolic process|
|cellular nitrogen compound catabolic process|
|aromatic compound catabolic process|
|ribonucleoprotein complex biogenesis|
|ncRNA metabolic process|
|organic cyclic compound catabolic process|
|posttranscriptional regulation of gene expression|
|modification-dependent macromolecule catabolic process|
|mRNA metabolic process|
|regulation of cellular catabolic process|
|nucleolus|
|RNA processing|
|cellular macromolecule catabolic process|
|regulation of catabolic process|
|macromolecule catabolic process|
|RNA binding|
|RNA metabolic process|
|negative regulation of gene expression|
|organic substance catabolic process|
|cellular catabolic process|
|gene expression|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp28|Pimelic-diphenylamide-106 5μM R00 exp28]]|-2.65|
|[[:results:exp498|Lead acetate 2000μM R08 exp498 no dilution day6]]|-1.93|
|[[:results:exp3|Actinomycin-D 0.001μM R00 exp3]]|-1.87|
|[[:results:exp7|Bortezomib 0.05μM R00 exp7]]|-1.73|
|[[:results:exp279|D-Fructose 10000μM R06 exp279]]|1.71|
|[[:results:exp458|Bisphenol S 100μM R08 exp458]]|3.02|
^Gene^Correlation^
|[[:human genes:g:golga6l1|GOLGA6L1]]|0.468|
|[[:human genes:p:prim1|PRIM1]]|0.415|
|[[:human genes:c:cox7a2l|COX7A2L]]|0.409|
Global Fraction of Cell Lines Where Essential: 197/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|1/1|
|bile duct|2/28|
|blood|9/28|
|bone|8/26|
|breast|7/33|
|central nervous system|11/56|
|cervix|0/4|
|colorectal|7/17|
|esophagus|1/13|
|fibroblast|0/1|
|gastric|2/16|
|kidney|8/21|
|liver|3/20|
|lung|24/75|
|lymphocyte|6/16|
|ovary|8/26|
|pancreas|8/24|
|peripheral nervous system|10/16|
|plasma cell|5/15|
|prostate|0/1|
|skin|4/24|
|soft tissue|2/9|
|thyroid|0/2|
|upper aerodigestive|9/22|
|urinary tract|5/29|
|uterus|1/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 296
* **Expression level (log2 read counts)**: 5.49
{{:chemogenomics:nalm6 dist.png?nolink |}}